BUZZ BOMB™ captures over 400,000 views and a spike in online revenue driven by strategic brand expansion and Ashley ...
Study represents a significant advancement in Grove’s Bionic Biologics™ platform – CHICAGO--(BUSINESS WIRE)--February 24, 2026-- Grove Biopharma, ...
Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today ...
ESTERO, FLORIDA / ACCESS Newswire / February 11, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary ...
New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...
Eli Lilly’s scope in cancer is expanding to radiopharmaceuticals with the $1.4 billion acquisition of Point Biopharma Global, a company in late-stage clinical development with two programs, one of ...
GSK to acquire clinical-stage biopharma company, 35Pharma Inc for $950 million: London, UK Thursday, February 26, 2026, 09:00 Hrs [IST] GSK plc announced that it has entered an ag ...
Therapeutic breakthroughs and innovations driving the next era of personalized medical care BOSTON, MA, UNITED STATES, ...
Just as a disciplined a soccer player might pass on a hopeful shot in favor of a better chance later on, the biopharma ...
As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the returning administration’s effect on issues like Medicaid spending, the future ...